◆ 会议时间：2024年8月25-28日
◆ 会议地点：智利 圣地亚哥

◆ 会议简介：

2024年第36届国际环境流行病学协会(ISEE)年会将于2024年8月25日至28日在智利圣地亚哥举行。

国际环境流行病学学会(ISEE)起源于1987年，是一个包括拉丁美洲、地中海、欧洲和东亚60多个国家和地区分支机构和地方团体成员的国际组织。ISEE成员讨论的主题包括环境暴露（如空气污染，危险废物，重金属，农药，辐射），健康影响（如癌症，心血管疾病，神经系统影响，生殖影响），方法学（如生物标志物，生态调查，实验设计，暴露/剂量评估，Meta分析，风险评估，统计），环境-基因相互作用以及道德与法律。ISEE会员来自于流行病学、暴露评估和科学，毒理学，生物化学和生物统计学等学科。ISEE为相关人员探讨健康与环境研究方面独特的问题提供了一个平台。ISEE的使命是宣促进环境暴露对人群影响的流行病学研究；鼓励卫生专业人士之间的沟通；促进方法学的进步，加强环境卫生政策等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

ISEE 2024
36th Annual Conference of the International Society for Environmental Epidemiology

Date：August 25-28, 2024
Venue: Santiago, Chile

摘要征文投稿：

Abstract Submission Deadline is February 7, 2024, 23:59 (GMT -3).

点此提交摘要>>>Submit Abstract>>>

Please take a moment to read the below guidelines before submitting your abstract:

IMPORTANT WARNING!

Please use the same e-mail address and same Name-Surname while submitting your abstract via the portal and registering for the conference. Different e-mail addresses and name formats might disrupt communications concerning your registration and abstracts.

ABSTRACT SUBMISSION GUIDELINES

• All abstracts must be written in English.
• All abstracts must be submitted online through the abstract submission system by the deadline given above. Abstracts that are sent via e-mail will not be included in the abstract review process.
• Please do NOT submit multiple copies of the same abstract.
• Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
• The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before submission.
• Always make sure to check the final abstract with the system’s preview function before submission and edit or replace as necessary. It is the authors’ responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
• Only the accepted abstracts of presenting authors who have completed their registrations and paid their registration fees by the registration deadline for abstract presenters will be included in the Scientific Program.
• A maximum of one oral and (or) two poster presentations can be made by one presenter.

ABSTRACT PREPARATION AND SUBMISSION ON THE SYSTEM

STEP 1- Presentation Options

• Topic/Sub-Topic: A main topic that is relevant for your abstract must be selected during Step 1 of the submission process. The Scientific Committee reserves the right to change the topics during the abstract review process.
• The topics for the 36th Annual Conference of the International Society for Environmental Epidemiology are listed on the Conference website. Please CLICK HERE to review the topics before proceeding with the submission process.
• Presentation type: Please choose one of the following:

• • In-person oral presentation
  • In-person poster presentation
  • Virtual oral presentation
  • Virtual poster presentation

The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific program. Oral presentations can be converted to poster presentations depending on slot availability.

STEP 2 – Institution Information

• The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.
• The department and institution details, city and country should be written in lower case, with the initials of each word capitalized.
• Enter each affiliation only once: If there are 5 authors and 3 are from the same affiliation and 2 are from another, you will have 2 institutions, NOT 5. However, if there are 2 or more departments represented at the same institution, they should be entered separately.
• If any of the authors have more than one affiliation, enter both affiliations in a compounded style as one affiliation: If there are 5 authors and 2 are from same affiliation (Institute A), 2 are from another (Institute B), and 1 is from both affiliations (Institutes A and B), you will have 3 institutions, NOT 5 and NOT 2. (First institution: Institute A, second one: Institute B, and the third one: Institute A & Institute B).
• Please make sure to include the City and Country information at the end of each institution. For the US, please make sure to enter the country information as “United States” or “US” after writing the state name or its abbreviation. For the UK, please write the country name as “United Kingdom” or “UK.”

STEP 3 – Author Information

• The first, middle, and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to matching the institutions from the dropdown menu to the right authors, and make sure that you select the “presenting author” correctly.

 
STEP 4 – Presenting Author Information

• Please enter the presenting author’s contact information correctly.

It’s highly important for you to ensure that the e-mail address of the presenting author is entered correctly, as all communication regarding the acceptance, any required adjustments, and scheduling will be sent to the presenting author via e-mail by the Conference Organizing Secretariat.

• The presenting author will be required to register for the Conference to confirm acceptance of the abstract.

STEP 5 – Abstract Title

• An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
• Abstract titles can contain a maximum of 20 words.
• Titles should not be written with all capitals.
• Use only generic drug names. Brand, product, or company names must not be used in the abstract title or text. The International Society for Environmental Epidemiology and/or the Organizing and Scientific Committees reserve the right to replace any brand name with a generic name.

STEP 6 – Abstract

• Abstract Body: The abstract body should not exceed 300 words. The title of the abstract, authors, institutions, and keywords are not included in this limit, and those should not be entered in this section.
• Abstract body should consist of the four sections given below:
  
  • Objective: Clearly state the purpose of the abstract. Briefly describe the objectives of the study unless they are contained in the title.
  • Material and Methods: Describe your selection of observations or experimental subjects clearly. Include a brief statement of methods if pertinent.
  • Results: Present your results in a logical sequence in text, table, and illustrations. State findings in sufficient detail to support conclusions.
  • Conclusion: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
• Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
• Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
• Do not include the names or personal information of any patient participating in a study or trial.
• Phrases such as “results will be discussed” or “data will be presented” shall not be used.
• Please mention all sources of funding for the work described and other acknowledgements briefly at the end of the abstract text.
• To be compatible with the universal coding system, only the special characters provided on the system should be used. Please note that the abstracts in which other special characters are used may not be displayed correctly in publications due to the coding systems.
• Use only generic drug names. Brand, product, or company names must not be used in the abstract title or text. The International Society for Environmental Epidemiology and/or Organizing and Scientific Committees reserve the right to replace any brand name with a generic name.

STEP 7 – Keywords

• Keywords should not be included in any of the sections of the abstract body and written only in the section dedicated to keywords.
• Minimum 2 keywords are required, and maximum 6 keywords can be entered. All keywords should be separated with commas and MUST be selected from the Keywords list which can be found HERE.
• All keywords should be written in lower case and separated with comma (,). Please do NOT use comma for anything else in the keywords section.

STEP 8 – Additional Files

• Images, tables, diagrams, and graphs are NOT accepted.

STEP 9 – Preview & Check

• The submitting authors are required to preview the abstract at this step and confirm the preview at this step.
• Any comments and/or additional information to be shared with the Scientific Committee can be submitted through the comment box.

STEP 10 – Submit to the Committee

• It is required to answer all questions before submitting your abstract. Please select/check your answer and then click on the “Choose” button for each one.
• If you have not completed all the required sections of your abstract, you won’t see the submission button. Only after completing all required fields, the submission button will be enabled for you.

AFTER SUBMISSION

• When the submission process is finalized, you will see your abstract under the heading “Submitted Abstracts”. If your abstract is not seen there, please kindly turn back and check the steps of your submission. Please be aware that the Scientific Committee will not receive “Not-Submitted Abstracts” and these therefore CANNOT be taken into consideration in the abstract review process.
• Upon submitting of your abstract an e-mail including the “Abstract Number” and “Abstract Title” will be sent to the submitting author. Please make sure to save your username and password for future use. If you cannot remember your credentials, please get in contact with the Conference Organizing Secretariat at ekose@kenes.com
• You can make edits on your abstract before submitting it to the Scientific Committee. After the submission is completed, no edits will be allowed on the system even if there is time until the deadline. In that case, if you have to make some edits on your abstract after submitting but before the submission deadline, please contact with the Conference Organizing Secretariat at ekose@kenes.com.

REVIEW PROCESS AND ACCEPTANCE LETTERS

All submitted abstracts will be scored and passed through a review process after the submission closes. The notification letters about acceptance of the abstracts including the presentation details (date, time, venue, presentation number, etc.) will be sent to the presenter author’s e-mail address.

REGISTRATION OF ABSTRACT PRESENTERS

The presenting author(s) must be registered for the Conference latest by April 3, 2024, which is the registration deadline for abstract presenters.

The abstracts of unregistered presenting authors who do not complete registration (including payment) by this deadline will be removed from the final program and all publications.

***

Thank you for submitting your work for consideration. Please contact us directly at ekose@kenes.com, should you have any specific inquiries.

The abstract submission system will close by the deadline of February 7, 2024, 23:59 (GMT -3).  Please make sure to check your time difference to determine the submission deadline according to your local time.

Dear friends, colleagues, interested citizens, ISEE Community,

We are delighted to invite you to attend the 36th Annual ISEE Conference in Santiago, Chile between August 25-28, 2024. The main theme of the conference is “Addressing challenges in environmental health, justice, and development”. We will address how the scientific community faces current health environmental justice, and epidemiological challenges, including empirical evidence, methodological approaches, ethical and theoretical developments.

Yours sincerely,
on behalf of the LAC chapter and Chilean Local Organizing Committee

María Elisa Quinteros Cáceres, PhD MSc,DDS
Public Health Department
Health Sciences Faculty
University of Talca

Verónica Iglesias A, PhD MSc
Public Health School
Medicine Faculty
University of Chile

注册费：

◆ 参会对象：政府代表、医院管理者、医护人员及该领域科研人员、医药企业代表等。